Nanochemoprevention: Sustained Release of Bioactive Food Components for Cancer Prevention

REFERENCES

• Surh , Y J . 2003 . Cancer chemoprevention with dietary phytochemicals . Nat Rev Cancer , 3 : 768 – 780 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Afaq , F , Adhami , V M and Mukhtar , H . 2008 . Prevention of prostate cancer through custom tailoring of chemopreventive regimen . Chem Biol Interact , 171 : 122 – 132 .
   PubMed Web of Science ®Google Scholar
• Khan , N , Afaq , F and Mukhtar , H . 2008 . Cancer chemoprevention through dietary antioxidants: progress and promise . Antioxid Redox Signal , 10 : 475 – 510 .
   PubMed Web of Science ®Google Scholar
• Syed , D N , Khan , N , Afaq , F and Mukhtar , H . 2007 . Chemoprevention of prostate cancer through dietary agents: progress and promise . Cancer Epidemiol Biomarkers Prev , 16 : 2193 – 2203 .
   PubMed Web of Science ®Google Scholar
• Bode , A M and Dong , Z . 2009 . Cancer prevention research—then and now . Nat Rev Cancer , 9 : 508 – 516 .
   PubMed Web of Science ®Google Scholar
• Amin , A R , Kucuk , O , Khuri , F R and Shin , D M . 2009 . Perspectives for cancer prevention with natural compounds . J Clin Oncol , 27 : 2712 – 2725 .
   PubMed Web of Science ®Google Scholar
• Greenwald , P . 2004 . Clinical trials in cancer prevention: current results and perspectives for the future . J Nutr , 134 : 3507S – 3512S .
   PubMed Web of Science ®Google Scholar
• Khan , N , Adhami , V M and Mukhtar , H . 2008 . Apoptosis by dietary agents for prevention and treatment of cancer . Biochem Pharmacol , 76 : 1333 – 1339 .
   PubMed Web of Science ®Google Scholar
• Ferrari , M . 2005 . Cancer nanotechnology: opportunities and challenges . Nat Rev Cancer , 5 : 161 – 171 .
   PubMed Web of Science ®Google Scholar
• Nishiyama , N . 2007 . Nanomedicine: nanocarriers shape up for long life . Nat Nanotechnol , 2 : 203 – 204 .
   PubMed Web of Science ®Google Scholar
• Nie , S , Xing , Y , Kim , G J and Simons , J W . 2007 . Nanotechnology applications in cancer . Annu Rev Biomed Eng , 9 : 257 – 288 .
   PubMed Web of Science ®Google Scholar
• Niemeyer , C M . 2001 . Semi-synthetic nucleic acid-protein conjugates: applications in life sciences and nanobiotechnology . J Biotechnol , 82 : 47 – 66 .
   PubMedGoogle Scholar
• Siddiqui , I A , Adhami , V M , Bharali , D J , Hafeez , B B Asim , M . 2009 . Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate . Cancer Res , 69 : 1712 – 1716 .
   PubMed Web of Science ®Google Scholar
• Gref , R , Minamitake , Y , Peracchia , M T , Trubetskoy , V Torchilin , V . 1994 . Biodegradable long-circulating polymeric nanospheres . Science , 263 : 1600 – 1603 .
   PubMed Web of Science ®Google Scholar
• Peer , D , Karp , J M , Hong , S , Farokhzad , O C Margalit , R . 2007 . Nanocarriers as an emerging platform for cancer therapy . Nat Nanotechnol , 2 : 751 – 760 .
   PubMed Web of Science ®Google Scholar
• Kawasaki , E S and Player , A . 2005 . Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer . Nanomedicine , 1 : 101 – 109 .
   PubMed Web of Science ®Google Scholar
• Gref , R , Domb , A , Quellec , P , Blunk , T Müller , RH . 1995 . The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres . Adv Drug Deliv Rev , 16 : 215 – 233 .
   PubMed Web of Science ®Google Scholar
• Deng , C , Tian , H , Zhang , P , Sun , J Chen , X . 2006 . Synthesis and characterization of RGD peptide grafted poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-glutamic acid) triblock copolymer . Biomacromolecules , 7 : 590 – 596 .
   PubMed Web of Science ®Google Scholar
• Mosqueira , V C , Legrand , P , Morgat , J L , Vert , M Mysiakine , E . 2001 . Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density . Pharm Res , 18 : 1411 – 1419 .
   PubMed Web of Science ®Google Scholar
• Stolnik , S , Dunn , S E , Garnett , M C , Davies , MC Coombes , AG . 1994 . Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers . Pharm Res , 11 : 1800 – 1808 .
   PubMed Web of Science ®Google Scholar
• Jemal , A , Siegel , R , Ward , E , Hao , Y Xu , J . 2009 . Cancer statistics . CA Cancer J Clin , 59 : 225 – 249 . 2009
   PubMed Web of Science ®Google Scholar
• Khan , N , Afaq , F , Saleem , M , Ahmad , N and Mukhtar , H . 2006 . Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate . Cancer Res , 66 : 2500 – 2505 .
   PubMed Web of Science ®Google Scholar
• Stuart , E C , Scandlyn , M J and Rosengren , R J . 2006 . Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer . Life Sci , 79 : 2329 – 2336 .
   PubMed Web of Science ®Google Scholar
• Saleem , M , Adhami , V M , Siddiqui , I A and Mukhtar , H . 2003 . Tea beverage in chemoprevention of prostate cancer: a mini-review . Nutr Cancer , 47 : 13 – 23 .
   PubMed Web of Science ®Google Scholar
• McLarty , J , Bigelow , R L , Smith , M , Elmajian , D Ankem , M . 2009 . Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro . Cancer Prev Res (Phila Pa) , 2 : 673 – 682 .
   PubMed Web of Science ®Google Scholar
• Butt , M S and Sultan , M T . 2009 . Green tea: nature's defense against malignancies . Crit Rev Food Sci Nutr , 49 : 463 – 473 .
   PubMed Web of Science ®Google Scholar
• Khan , N and Mukhtar , H . 2008 . Multitargeted therapy of cancer by green tea polyphenols . Cancer Lett , 269 : 269 – 280 .
   PubMed Web of Science ®Google Scholar
• Mukhtar , H and Ahmad , N . 1999 . Green tea in chemoprevention of cancer . Toxicol Sci , 52 : 111 – 117 .
   PubMed Web of Science ®Google Scholar
• Ahmad , N , Feyes , D K , Nieminen , A L , Agarwal , R and Mukhtar , H . 1997 . Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells . J Natl Cancer Inst , 89 : 1881 – 1886 .
   PubMed Web of Science ®Google Scholar
• Cao , Y and Cao , R . 1999 . Angiogenesis inhibited by drinking tea . Nature , 398 : 381
   PubMed Web of Science ®Google Scholar
• Daliani , D . 2000 . Development of angiogenesis inhibition as therapy for prostate cancer . Oncology (Williston Park) , 14 : 21 – 23 .
   PubMed Web of Science ®Google Scholar
• Pound , C R , Partin , A W , Eisenberger , M A , Chan , D W Pearson , J D . 1999 . Natural history of progression after PSA elevation following radical prostatectomy . JAMA , 281 : 1591 – 1597 .
   PubMed Web of Science ®Google Scholar
• Adhami , V M , Malik , A , Zaman , N , Sarfaraz , S Siddiqui , IA . 2007 . Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo . Clin Cancer Res , 13 : 1611 – 1619 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Malik , A , Adhami , V M , Asim , M Hafeez , BB . 2008 . Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis . Oncogene , 27 : 2055 – 2063 .
   PubMed Web of Science ®Google Scholar
• Zhang , L , Gu , F X , Chan , J M , Wang , A Z Langer , R S . 2008 . Nanoparticles in medicine: therapeutic applications and developments . Clin Pharmacol Ther , 83 : 761 – 769 .
   PubMed Web of Science ®Google Scholar
• Han , D W , Lee , J J , Jung , D Y , Park , J C and Hyon , S H . 2009 . Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations . Biomed Mater , 4 : 44104
   Web of Science ®Google Scholar
• Sahu , A , Bora , U , Kasoju , N and Goswami , P . 2008 . Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells . Acta Biomater , 4 : 1752 – 1761 .
   PubMed Web of Science ®Google Scholar
• Thangapazham , R L , Puri , A , Tele , S , Blumenthal , R and Maheshwari , R K . 2008 . Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells . Int J Oncol , 32 : 1119 – 1123 .
   PubMed Web of Science ®Google Scholar
• Italia , J L , Datta , P , Ankola , D D and Kumar , MNVR . 2008 . Nanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution . J Biomed Nanotechnol , 4 : 304 – 312 .
   Web of Science ®Google Scholar
• Das , R K , Kasoju , N and Bora , U . 2010 . Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells . Nanomedicine , 6 : 153 – 160 .
   PubMed Web of Science ®Google Scholar
• Merrell , J G , McLaughlin , S W , Tie , L , Laurencin , C T Chen , A F . 2009 . Curcumin loaded poly(epsilon-caprolactone) nanofibers: diabetic wound dressing with antioxidant and anti-inflammatory properties . Clin Exp Pharmacol Physiol , 36 : 1149 – 1156 .
   PubMed Web of Science ®Google Scholar
• Li , J , Wang , Y , Yang , C , Wang , P , Oelschlager , DK Zheng , Y . 2009 . Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1 . Mol Pharmacol , 76 : 81 – 90 .
   PubMed Web of Science ®Google Scholar
• Wang , D , Veena , M S , Stevenson , K , Tang , C Ho , B . 2008 . Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway . Clin Cancer Res , 14 : 6228 – 6236 .
   PubMed Web of Science ®Google Scholar
• Shao , J , Li , X , Lu , X , Jiang , C Hu , Y . 2009 . Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels . Colloids Surf B Biointerfaces , 72 : 40 – 47 .
   PubMed Web of Science ®Google Scholar
• Caddeo , C , Teskac , K , Sinico , C and Kristl , J . 2008 . Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells . Int J Pharm , 363 : 183 – 191 .
   PubMed Web of Science ®Google Scholar
• Lu , X , Ji , C , Xu , H , Li , X Ding , H . 2009 . Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress . Int J Pharm , 375 : 89 – 96 .
   PubMed Web of Science ®Google Scholar
• Hung , C F , Chen , J K , Liao , M H , Lo , H M and Fang , J Y . 2006 . Development and evaluation of emulsion-liposome blends for resveratrol delivery . J Nanosci Nanotechnol , 6 : 2950 – 2958 .
   PubMed Web of Science ®Google Scholar
• Narayanan , N K , Nargi , D , Randolph , C and Narayanan , B A . 2009 . Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice . Int J Cancer , 125 : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Shutava , T G , Balkundi , S S , Vangala , P , Steffan , JJ Bigelow , RL . 2009 . Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols . ACS Nano ,
   PubMed Web of Science ®Google Scholar